Kaken Pharmaceutical Co Stock Performance
| KKPCF Stock | USD 23.65 0.00 0.00% |
The company secures a Beta (Market Risk) of -0.73, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Kaken Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Kaken Pharmaceutical is likely to outperform the market. At this point, Kaken Pharmaceutical has a negative expected return of -0.21%. Please make sure to verify Kaken Pharmaceutical's variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and rate of daily change , to decide if Kaken Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Kaken Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Quick Ratio | 4.85 | |
| Fifty Two Week Low | 27.15 | |
| Payout Ratio | 62.35% | |
| Fifty Two Week High | 39.84 | |
| Trailing Annual Dividend Yield | 535.71% |
Kaken |
Kaken Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 2,745 in Kaken Pharmaceutical Co on September 28, 2025 and sell it today you would lose (380.00) from holding Kaken Pharmaceutical Co or give up 13.84% of portfolio value over 90 days. Kaken Pharmaceutical Co is currently producing negative expected returns and takes up 2.1058% volatility of returns over 90 trading days. Put another way, 18% of traded pink sheets are less volatile than Kaken, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Kaken Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kaken Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Kaken Pharmaceutical Co, and traders can use it to determine the average amount a Kaken Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0975
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KKPCF |
Based on monthly moving average Kaken Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kaken Pharmaceutical by adding Kaken Pharmaceutical to a well-diversified portfolio.
Kaken Pharmaceutical Fundamentals Growth
Kaken Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Kaken Pharmaceutical, and Kaken Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kaken Pink Sheet performance.
| Return On Equity | 6.65 | |||
| Return On Asset | 6.36 | |||
| Profit Margin | 12.00 % | |||
| Operating Margin | 22.04 % | |||
| Current Valuation | (68.22 B) | |||
| Shares Outstanding | 37.47 M | |||
| Price To Earning | 16.87 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 75.78 B | |||
| EBITDA | 19.23 B | |||
| Cash And Equivalents | 73.7 B | |||
| Total Debt | 3.85 B | |||
| Debt To Equity | 0.03 % | |||
| Cash Flow From Operations | 13.34 B | |||
| Earnings Per Share | 1.66 X | |||
About Kaken Pharmaceutical Performance
By analyzing Kaken Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Kaken Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kaken Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kaken Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. Kaken Pharmaceutical Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan. Kaken Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1164 people.Things to note about Kaken Pharmaceutical performance evaluation
Checking the ongoing alerts about Kaken Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Kaken Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kaken Pharmaceutical generated a negative expected return over the last 90 days | |
| About 13.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Kaken Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kaken Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Kaken Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kaken Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kaken Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kaken Pharmaceutical's pink sheet. These opinions can provide insight into Kaken Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Kaken Pink Sheet analysis
When running Kaken Pharmaceutical's price analysis, check to measure Kaken Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaken Pharmaceutical is operating at the current time. Most of Kaken Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Kaken Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kaken Pharmaceutical's price. Additionally, you may evaluate how the addition of Kaken Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |